• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Up 0.36%

    MannKind Corp. (MNKD)

    -NasdaqGM
    5.36 Down 0.05(0.92%) Dec 19, 4:00PM EST
    |After Hours : 5.60 Up 0.24 (4.48%) Dec 19, 7:53PM EST
    Add to Portfolio
    Prev Close:5.41
    Open:5.44
    Bid:N/A
    Ask:5.62 x 500
    1y Target Est:8.93
    Beta:3.2
    Earnings Date:Feb 16 - Feb 20 (Est.)
    Day's Range:5.27 - 5.45
    52wk Range:3.80 - 11.48
    Volume:8,064,564
    Avg Vol (3m):5,024,340
    Market Cap:2.13B
    P/E (ttm):N/A
    EPS (ttm):-0.58
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    MNKDDown 0.92%2.13B
    LLYDown 0.07%77.44B
    GSKUp 0.14%104.21B
    NVODown 1.33%114.51B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.48
    Quarterly EPS Est (Dec-14) :-0.09
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):0.05

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback